Benchmark Upgrades HeartBeam to Buy, Maintains Price Target to $8

Benzinga · 3d ago
Benchmark analyst Bill Sutherland upgrades HeartBeam (NASDAQ:BEAT) from Speculative Buy to Buy and maintains the price target from $8 to $8.